Back to VANGUARD GROUP INC VANGUARD GROUP INC

CTXRCTXR
5 quarters

Position history for VANGUARD GROUP INCVANGUARD GROUP INC's holdings in CITIUS PHARMACEUTICALS INC

VANGUARD GROUP INC holds 199,258 shares of CTXR (CITIUS PHARMACEUTICALS INC), worth $154,824 as of 2025-Q4. The position was increased (+19.8% shares).

Current Value

$154,824

Current Shares

199,258

Total Value Change

-$875,700

Total Shares Change

-58,373

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Increased
199,258
+19.8%
$154,8240.0%$0.78
18
2025-Q3
Increased
166,390
+107.7%
$206,3230.0%$1.18
25
2025-Q2
Decreased
80,103
-68.9%
$127,3640.0%$1.53
0
2025-Q1
Unchanged
257,631
0.0%
$383,8700.0%$1.55
0
2024-Q4
New
257,631
-
$1M0.0%$3.91
38

Other major holders of CTXR: UBS Group AG, GEODE CAPITAL MANAGEMENT, LLC, BlackRock, Inc., Squarepoint Ops LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used